Does NAD+ Decline With Age in Humans? The Tissue-by-Tissue Evidence and How It Was Measured
Human skin, brain, CSF, muscle, liver and blood studies of NAD+ and age, the methods behind them, and why results conflict. Lab research only.
Human skin, brain, CSF, muscle, liver and blood studies of NAD+ and age, the methods behind them, and why results conflict. Lab research only.
Rat tendon, ligament, muscle, junction and bone models for BPC-157, the mixed thymosin beta-4 record and the one combination study. Lab only.
What GHK and GHK-Cu did in radical-chemistry, macrophage, lung injury, emphysema, asthma, colitis and zebrafish models, and the caveats. Lab only.
SURMOUNT-OSA in detail: AHI and hypoxic burden results, how much is weight loss, subgroups, and the missing outcome data. Lab research only.
Which skin wound models BPC-157, thymosin beta-4/LKKTETQ and GHK-Cu were tested in, what was measured, and the missing combination study. Lab only.
How MOTS-c was studied in diet-induced obesity, NASH, NOD, gestational and streptozotocin diabetes models, and what they cannot show. Lab research only.
What phase 1-3 retatrutide trials report on adverse events: GI effects, escalation, heart rate, hypotension and dysaesthesia. Lab research only.
Published stability data for NAD+ and NADH: hydrolysis and hydration routes, buffer and temperature effects, anomers and handling artefacts. Lab only.
Rodent reperfusion studies, collateral-vessel claims and the contradictory thymosin beta-4 cardiac record, including negative results. Lab research only.
How the GRF sequence degrades, which impurity classes a synthetic preparation carries, and the LC-MS methods used to detect it. Lab research only.